Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) FCF Margin (2019 - 2025)

AVITA Medical's FCF Margin history spans 7 years, with the latest figure at 6.44% for Q4 2025.

  • For Q4 2025, FCF Margin rose 8508.0% year-over-year to 6.44%; the TTM value through Dec 2025 reached 21.86%, up 6860.0%, while the annual FY2025 figure was 44.45%, 4599.0% up from the prior year.
  • FCF Margin reached 6.44% in Q4 2025 per RCEL's latest filing, up from 27.37% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 5.57% in Q2 2022 to a low of 198.23% in Q1 2024.
  • Average FCF Margin over 5 years is 69.55%, with a median of 75.65% recorded in 2023.
  • Peak YoY movement for FCF Margin: soared 14803bps in 2021, then tumbled -11223bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 8.53% in 2021, then plummeted by -381bps to 41.05% in 2022, then crashed by -92bps to 78.61% in 2023, then fell by -16bps to 91.52% in 2024, then soared by 93bps to 6.44% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's FCF Margin are 6.44% (Q4 2025), 27.37% (Q3 2025), and 59.0% (Q2 2025).